BTIG Slices PT on Genworth (GNW) to $5; Sees Challenges Priced into Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- US stock futures dip as oil breaches $100 mark for the first time since mid-year
- Oil nears $100 as fresh Middle East strikes raise supply risks
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Compass Point Cuts Price Target on Genworth Financial (GNW) Following Valuation Shift on MI Companies
February 8, 2016 6:45 AM ESTCompass Point maintained a Buy rating on Genworth Financial (NYSE: GNW), and cut the price target to $5.50 (from $7.50), following the recent shift to lower valuation on MI companies. GNW intends to separate its MI and life operations, which should be viewed positively by the market place. However, the lack of substance on how the company will proceed and the market's meek anticipation of success continues to keep pressure on GNW shares.
Analyst Ken Billingsley commented, "We lower our price target to $5.50 from $7.50, primarily on the... More
Genworth Financial (GNW) Posts Q4 Loss of 17c/Share; Will Initiate U.S. Life Restructuring Plan
February 4, 2016 4:48 PM ESTGenworth Financial (NYSE: GNW) reported Q4 EPS of ($0.17), which may not compare with the analyst estimate of $0.21. Revenue for the quarter came in at $0 versus the consensus estimate of $2.17 billion.
Strategic Update
In 2016, the company plans to initiate a series of internal restructuring actions aimed at separating and isolating its LTC business, subject to regulatory and other potential third-party approvals. These actions are focused on addressing LTC legacy block issues that continue to pressure ratings across the organization.
Also, the company has decided to suspend all sales of traditional life... More
